Meridian Wealth Management, LLC Adma Biologics, Inc. Transaction History

Meridian Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$2.47 - $3.88 $81,510 - $128,040	-33,000 Reduced 66.0%	17,000 $65,000
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $60,899 - $85,800	-30,000 Reduced 37.5%	50,000 $122,000
Q2 2022 Aug 05, 2022	SELL	$1.43 - $2.2 $100,100 - $154,000	-70,000 Reduced 46.67%	80,000 $158,000
Q4 2021 Jan 27, 2022	SELL	$1.09 - $1.66 $61,040 - $92,960	-56,000 Reduced 27.18%	150,000 $212,000
Q3 2021 Oct 15, 2021	BUY	$1.13 - $1.65 $47,459 - $69,300	42,000 Added 25.61%	206,000 $233,000
Q2 2021 Jul 22, 2021	BUY	$1.51 - $2.07 $96,640 - $132,480	64,000 Added 64.0%	164,000 $262,000
Q4 2020 Jan 19, 2021	BUY	$1.8 - $2.56 $72,000 - $102,400	40,000 Added 66.67%	100,000 $195,000
Q3 2020 Oct 09, 2020	BUY	$2.04 - $3.74 $81,600 - $149,600	40,000 Added 200.0%	60,000 $143,000
Q2 2020 Jul 15, 2020	BUY	$2.42 - $3.29 $48,400 - $65,800	20,000 New	20,000 $58,000

314

187M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.22B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Wealth Management, LLC with notifications on news.